Holen Sie sich die Stockscreener-App
1.40
3.78%
-0.055
Vorhandelsmarkt:
1.39
-0.01
-0.71%
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
Neuronetics Reports Higher Revenue, Narrows Loss, Sets 2026 Outlook - MyChesCo
Neuronetics (NASDAQ:STIM) Director Sells $62,027.26 in Stock - MarketBeat
Neuronetics (NASDAQ:STIM) EVP Steven Pfanstiel Sells 16,431 Shares - MarketBeat
Neuronetics appoints Dan Reuvers as CEO, succeeding Keith Sullivan - MSN
Published on: 2026-03-25 12:08:27 - baoquankhu1.vn
Top Neuronetics Insiders Quietly Unload a Wave of Shares in Rapid-Fire Moves - TipRanks
Neuronetics EVP Macan sells $21k in shares By Investing.com - Investing.com South Africa
Neuronetics: former officer Sullivan sells $62k in shares By Investing.com - Investing.com South Africa
Neuronetics EVP Pfanstiel sells $22k in shares By Investing.com - Investing.com Australia
Neuronetics EVP Pfanstiel sells $22k in shares - Investing.com
Neuronetics: former officer Sullivan sells $62k in shares - Investing.com
Neuronetics EVP Macan sells $21k in shares - Investing.com
Neuronetics (STIM) CFO Pfanstiel sells 16,431 shares to cover tax withholding - Stock Titan
Neuronetics (STIM) ex-officer sells 46,289 shares to cover tax withholding - Stock Titan
Neuronetics (STIM) EVP Macan sells 16,005 shares to cover RSU tax - Stock Titan
Neuronetics Appoints Dan Reuvers as CEO, Succeeding Keith Sullivan - MyChesCo
Layoff Watch: Does Neuronetics Inc have pricing power2026 Technical Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Neuronetics (STIM) CEO awarded 1,500,000 restricted stock units in equity grant - Stock Titan
Neuronetics (STIM) CEO Daniel Reuvers named as insider in Form 3 - Stock Titan
Insider Buying: Jorey Chernett Acquires Additional Shares of Neu - GuruFocus
Insider Buying: Neuronetics (NASDAQ:STIM) Major Shareholder Buys $238,955.52 in Stock - MarketBeat
Chernett Jorey buys Neuronetics (STIM) shares worth $238,955 By Investing.com - Investing.com Australia
Chernett Jorey buys Neuronetics (STIM) shares worth $238,955 - Investing.com
Major Neuronetics (NASDAQ: STIM) holder adds 169K shares - Stock Titan
Neuronetics: Highly Speculative, But Revenue Growth Could Drive The Stock Higher (STIM) - Seeking Alpha
Malvern’s Neuronetics Announces New CEO as 2025 Revenue Nearly Doubles to $149M - BUCKSCO.Today
Neuronetics (NASDAQ:STIM) Stock Rating Lowered by Wall Street Zen - MarketBeat
Major Investor Makes Bold Move Into Neuronetics Stock - TipRanks
Form 144 Neuronetics For: 19 March By Investing.com - Investing.com Australia
Insider Buying: Neuronetics (NASDAQ:STIM) Major Shareholder Acquires $819,990.00 in Stock - MarketBeat
Jorey Chernett Buys 450,000 Shares of Neuronetics (NASDAQ:STIM) Stock - MarketBeat
Insider Buying: Jorey Chernett Acquires 1,057,400 Shares of Neur - GuruFocus
Chernett Jorey buys Neuronetics (STIM) shares worth $1.42 million - Investing.com UK
Neuronetics 10% Owner Purchased Shares Worth Over $1.4M - TradingView
Chernett Jorey buys Neuronetics (STIM) shares worth $1.42 million By Investing.com - Investing.com Australia
Neuronetics Insider Bought Shares Worth $1,418,490, According to a Recent SEC Filing - marketscreener.com
Neuronetics (NASDAQ: STIM) 10% holder buys 1,057,400 shares - Stock Titan
STIM (NASDAQ: STIM) Form 144: insider resale notice for 16,005 shares - Stock Titan
STIM (NASDAQ: STIM) notice: proposed sale of 46,289 common shares - Stock Titan
Canaccord Genuity Group Lowers Neuronetics (NASDAQ:STIM) Price Target to $3.00 - MarketBeat
STIM: Neuronetics Analyst Rating UpdateMarch 19, 2026 | STIM Stock News - GuruFocus
Neuronetics, Inc. (NASDAQ:STIM) Q4 2025 Earnings Call Transcript - Insider Monkey
Form 144 Neuronetics For: 19 March - Investing.com
[Form 4] Neuronetics, Inc. Insider Trad... - Stock Titan
Neuronetics (STIM) EVP receives 33,750 performance-based common shares - Stock Titan
Neuronetics (STIM) CFO awarded 25,000 RSUs vesting from 2027 - Stock Titan
This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain - AOL.com
Neuronetics to Spotlight Expanding Mental Health Therapies at Major Industry Forum - MSN
Canaccord cuts Neuronetics stock price target on valuation shift By Investing.com - Investing.com India
Neuronetics (NASDAQ:STIM) Major Shareholder Acquires 531,000 Shares - MarketBeat
Insider Buying: Jorey Chernett Acquires 531,000 Shares of Neuron - GuruFocus
This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names - AOL.com
Neuronetics Insider Bought Shares Worth $615,960, According to a Recent SEC Filing - marketscreener.com
Neuronetics 10% Owner Purchased Shares Worth Over $615K - TradingView
Large Neuronetics (STIM) insider purchase adds 531,000 shares at $1.16 - Stock Titan
Large Neuronetics (STIM) holder discloses 6,985,404-share position - Stock Titan
Prenuvo CEO bets he can save lives and major healthcare spending by ‘inverting the pyramid’ - AOL.com
Canaccord cuts Neuronetics stock price target on valuation shift - Investing.com
Neuronetics, Inc. Stock Plummets to New 52-Week Low of $0.80 - Markets Mojo
[SCHEDULE 13G/A] Neuro... - Stock Titan
Neuronetics revenue up 86% to USD 41.8M in Q4 2025 - Medical Buyer
Neuronetics names Dan Reuvers as CEO effective March 23 By Investing.com - Investing.com South Africa
1.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):